Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Shermock

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 8, 2003
Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiencyThomas R Gildea, Kenneth M Shermock, Mendel E Singer, et al.
The American Journal of Managed Care|April 19, 2018
Limited distribution networks stifle competition in the generic and biosimilar drug industriesLaura Karas, Kenneth M Shermock, Celia Proctor, et al.
JAMA|January 22, 2021
Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020Matthew A Crane, Kenneth M Shermock, Saad B Omer, et al.
The Pediatric Infectious Disease Journal|August 28, 2007
No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infectionsJillian M Szczesiul, Kenneth M Shermock, Umbreen Idrees Murtaza, et al.
Critical Care Medicine|March 9, 2005
Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patientsKenneth M Shermock, Ed Horn, Pamela A Lipsett, et al.
Neurocritical Care|January 21, 2011
The use of lacosamide in refractory status epilepticusHaley Goodwin, Holly E Hinson, Kenneth M Shermock, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2002
Service use and costs among VA patients with schizophrenia taking risperidone or olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day ReadmissionJodi B Segal, Ariella Apfel, Daniel J Brotman, et al.
Diabetes Research and Clinical Practice|October 31, 2015
Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Type 2 diabetes patients in sub-Saharan AfricaSangeeta Tandon, Melissa Chew, Christophe Kwashie Eklu-Gadegbeku, et al.
Hospital Pharmacy|February 6, 2019
The Effect of Performance Transparency on Adherence to Barcode Scanning During Order Preparation in an Adult Inpatient Satellite PharmacyDavid Merola, John D Hill, Stephanie Olumba, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|February 8, 2003
Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiencyThomas R Gildea, Kenneth M Shermock, Mendel E Singer, et al.
The American Journal of Managed Care|April 19, 2018
Limited distribution networks stifle competition in the generic and biosimilar drug industriesLaura Karas, Kenneth M Shermock, Celia Proctor, et al.
JAMA|January 22, 2021
Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020Matthew A Crane, Kenneth M Shermock, Saad B Omer, et al.
The Pediatric Infectious Disease Journal|August 28, 2007
No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infectionsJillian M Szczesiul, Kenneth M Shermock, Umbreen Idrees Murtaza, et al.
Critical Care Medicine|March 9, 2005
Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patientsKenneth M Shermock, Ed Horn, Pamela A Lipsett, et al.
Neurocritical Care|January 21, 2011
The use of lacosamide in refractory status epilepticusHaley Goodwin, Holly E Hinson, Kenneth M Shermock, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2002
Service use and costs among VA patients with schizophrenia taking risperidone or olanzapineMatthew A Fuller, Kenneth M Shermock, Michelle Secic, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day ReadmissionJodi B Segal, Ariella Apfel, Daniel J Brotman, et al.
Diabetes Research and Clinical Practice|October 31, 2015
Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Type 2 diabetes patients in sub-Saharan AfricaSangeeta Tandon, Melissa Chew, Christophe Kwashie Eklu-Gadegbeku, et al.
Hospital Pharmacy|February 6, 2019
The Effect of Performance Transparency on Adherence to Barcode Scanning During Order Preparation in an Adult Inpatient Satellite PharmacyDavid Merola, John D Hill, Stephanie Olumba, et al.
Pageof 8